POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% Drug Patent Profile
✉ Email this page to a colleague
When do Potassium Chloride 0.3% And Sodium Chloride 0.9% patents expire, and what generic alternatives are available?
Potassium Chloride 0.3% And Sodium Chloride 0.9% is a drug marketed by Baxter Hlthcare, Fresenius Kabi Usa, and B Braun. and is included in three NDAs.
The generic ingredient in POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% is dextrose; potassium chloride; sodium chloride. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dextrose; potassium chloride; sodium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%?
- What are the global sales for POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%?
- What is Average Wholesale Price for POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%?
Summary for POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 3 |
DailyMed Link: | POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% at DailyMed |
Pharmacology for POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9%
Drug Class | Osmotic Laxative Potassium Salt |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |